Inhibitors of checkpoint kinases

Details for Australian Patent Application No. 2006269504 (hide)

Owner Merck & Co., Inc.

Inventors Garbaccio, Robert M.; Hartman, George D.; Tasber, Edward S.; Dudkin, Vadim Y.; Fraley, Mark E.; Kreatsoulas, Constantine; Huang, Shaei Y.; Arrington, Kenneth L.

Agent Spruson & Ferguson

Pub. Number AU-A-2006269504

PCT Pub. Number WO2007/008502

Priority 60/697,817 08.07.05 US

Filing date 30 June 2006

Wipo publication date 18 January 2007

International Classifications

C07D 221/10 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2007/008502 Priority application(s): WO2007/008502

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp. Amendments

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006269513-Medical connector with closeable male luer

2006269503-Antidiabetic oxazolidinediones and thiazolidinediones